Pyridine, 4-isocyanato-
- Product Name
- Pyridine, 4-isocyanato-
- CAS No.
- 70067-45-7
- Chemical Name
- Pyridine, 4-isocyanato-
- Synonyms
- 4-Pyridyl isocyanate;4-isocyanate pyridine;Pyridin-4-yl isocyanate;Pyridine, 4-isocyanato-
- CBNumber
- CB72640232
- Molecular Formula
- C6H4N2O
- Formula Weight
- 120.11
- MOL File
- 70067-45-7.mol
Pyridine, 4-isocyanato- Property
- Melting point:
- 160-161 °C
- Boiling point:
- 181.9±13.0 °C(Predicted)
- Density
- 1.12±0.1 g/cm3(Predicted)
- pka
- 4.83±0.10(Predicted)
Safety
- Hazard Codes
- T
- Risk Statements
- 22-23-36-42/43
- Safety Statements
- 22-26-36/37-45
- RIDADR
- UN 2811 6.1 / PGIII
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Danger
- Hazard statements
-
H302Harmful if swallowed
H317May cause an allergic skin reaction
H319Causes serious eye irritation
H331Toxic if inhaled
H334May cause allergy or asthma symptoms or breathing difficulties if inhaled
- Precautionary statements
-
P261Avoid breathing dust/fume/gas/mist/vapours/spray.
P280Wear protective gloves/protective clothing/eye protection/face protection.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
P311Call a POISON CENTER or doctor/physician.
N-Bromosuccinimide Price
- Product number
- 080150
- Product name
- 4-Isocyanatopyridine
- Packaging
- 500mg
- Price
- $420
- Updated
- 2021/12/16
- Product number
- CHM0378344
- Product name
- 4-ISOCYANATOPYRIDINE
- Purity
- 95.00%
- Packaging
- 5MG
- Price
- $504.76
- Updated
- 2021/12/16
- Product number
- 080150
- Product name
- 4-Isocyanatopyridine
- Packaging
- 1g
- Price
- $525
- Updated
- 2021/12/16
- Product number
- 098360
- Product name
- Pyridine-4-isocyanate
- Packaging
- 25g
- Price
- $6400
- Updated
- 2021/12/16
- Product number
- Z2906
- Product name
- 4-Isocyanatopyridine
- Packaging
- 25g
- Price
- $8690
- Updated
- 2021/12/16
Pyridine, 4-isocyanato- Chemical Properties,Usage,Production
Uses
4-Isocyanatopyridine is used in the preparation of thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase as well as the preparation of pyridyl-substituted pyrazolotriazolopyrimidine as a water-soluble human A3 adenosine receptor antagonist.